Choice of the adequate quantification method for recombinant human GM-CSF produced in different host systems
Three enzyme-linked-immunosorbent assays (ELISA) were developed and compared with a bioassay to quantify the recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF). These assays were suitable to quantify the non-glycosylated rhGM-CSF present in mixtures with variable protein c...
Guardado en:
Autores principales: | Bollati Fogolín,Mariela, Eberhardt,Marcos Oggero, Kratje,Ricardo, Etcheverrigaray,Marina |
---|---|
Lenguaje: | English |
Publicado: |
Pontificia Universidad Católica de Valparaíso
2002
|
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-34582002000300008 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
T Cell Production of GM-CSF Protects the Host during Experimental Tuberculosis
por: Richard T. Robinson
Publicado: (2017) -
Recombinant human granulocyte-macrophage colony-stimulating factor: effect of glycosylation on pharmacokinetic parameters
por: Marini,Guillermo, et al.
Publicado: (2007) -
DIRECT EFFECTS OF GM-CSF ON THE FUNCTIONS OF HUMAN MONOCYTES/MACROPHAGES
por: N. D. Gazatova, et al.
Publicado: (2019) -
Clinical uses of GM-CSF, a critical appraisal and update
por: Martha Arellano, et al.
Publicado: (2008) -
CSF1R Inhibition Combined with GM-CSF Reprograms Macrophages and Disrupts Protumoral Interplays with AML Cells
por: Tatiana Smirnova, et al.
Publicado: (2021)